Cite

HARVARD Citation

    Singh, H. et al. (n.d.). A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19. Immunological reviews. 257 (1), pp. 181-190. [Online]. 
  
Back to record